We are live on ! Find out more
TELA icon

TELA Bio
TELA

47 hedge funds and large institutions have $146M invested in TELA Bio in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

20% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 15

7% more funds holding

Funds holding: 44 → 47 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.52% less ownership

Funds ownership: 67.68% → 67.16% (-0.52%)

10% less capital invested

Capital invested by funds: $161M → $146M (-$15.6M)

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
18
Reduced
15
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
Armistice Capital
New York
+$1.56M
2
State Street
State Street
Massachusetts
+$481K
3
RPC
Rossmore Private Capital
Connecticut
+$397K
4
PVI
Pura Vida Investments
New York
+$336K
5
WP
WMS Partners
Maryland
+$257K

Top Sellers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.85M
2
MAG
Millrace Asset Group
Pennsylvania
-$880K
3
SMH
Sanders Morris Harris
Texas
-$807K
4
SAM
Silvercrest Asset Management
New York
-$755K
5
CCM
CAAS Capital Management
New York
-$251K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$45.5M – – –
EWM
2
Essex Woodlands Management
Texas
$22.2M – – –
RI
3
RTW Investments
New York
$20.8M +$81.8K +5,040 +0.4%
CAC
4
Cowen and Company
New York
$6.04M -$117K -7,228 -2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$6M -$166K -10,249 -3%
OM
6
Opaleye Management
Massachusetts
$5.49M +$47.5K +2,926 +0.8%
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$5.22M -$1.85M -113,794 -25%
PVI
8
Pura Vida Investments
New York
$4.65M +$336K +20,718 +7%
BlackRock
9
BlackRock
New York
$4.61M +$210K +12,928 +4%
PCM
10
Pentwater Capital Management
Florida
$4.24M – – –
SAM
11
Silvercrest Asset Management
New York
$4.1M -$755K -46,510 -15%
AC
12
Armistice Capital
New York
$3.85M +$1.56M +96,000 +60%
SSA
13
Schonfeld Strategic Advisors
New York
$1.95M -$79.5K -4,900 -4%
SMH
14
Sanders Morris Harris
Texas
$1.71M -$807K -49,703 -30%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$1.44M +$203K +12,483 +15%
State Street
16
State Street
Massachusetts
$1.43M +$481K +29,652 +45%
Northern Trust
17
Northern Trust
Illinois
$1.16M -$48.2K -2,967 -4%
Nomura Holdings
18
Nomura Holdings
Japan
$771K +$107K +6,600 +15%
PNC Financial Services Group
19
PNC Financial Services Group
Pennsylvania
$710K – – –
RPC
20
Rossmore Private Capital
Connecticut
$519K +$397K +24,484 +245%
Squarepoint
21
Squarepoint
New York
$408K -$163K -10,054 -27%
Goldman Sachs
22
Goldman Sachs
New York
$306K -$168K -10,344 -34%
Charles Schwab
23
Charles Schwab
California
$279K – – –
JP Morgan Chase
24
JP Morgan Chase
New York
$273K +$215K +13,247 +270%
N
25
Nuveen
North Carolina
$272K – – –
1
2

TELA Hedge Fund Activity: Q4 2020 in Review

47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q4 2020, worth a combined $146M — down 9.7% from $161M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TELA positions and 1 closed out — a net gain of 3 holders — while 18 added to existing stakes and 15 trimmed.

The largest buyer was Armistice Capital, adding an estimated $1.56M. The largest seller was Alyeska Investment Group, cutting an estimated $1.85M.

  • 47 institutional investors held TELA Bio (TELA) as of Q4 2020, up from 44 in Q3 2020.
  • Funds reported $146M of TELA Bio stock for Q4 2020, down 9.7% quarter-over-quarter.
  • 4 funds opened new TELA Bio positions in Q4 2020 and 1 closed out, a net change of +3 holders.
  • The largest TELA Bio buyer in Q4 2020 was Armistice Capital, an estimated $1.56M added.
  • The largest TELA Bio seller in Q4 2020 was Alyeska Investment Group, an estimated $1.85M sold.

Based on aggregated 13F filings for Q4 2020.